Prevalencia de diabesidad en población laboral españolainfluencia de variables sociodemográficas y consumo de tabaco

  1. López-González, A.A. 1
  2. Ramírez Manent, J.I. 1
  3. Vicente-Herrero, M.T. 2
  4. García Ruiz, E. 3
  5. Albaladejo Blanco, M. 4
  6. López Safont, N. 3
  1. 1 Universitat de les Illes Balears. Palma de Mallorca. España.
  2. 2 Servicio Médico de Correos Valencia-Castellón. España.
  3. 3 Escuela Universitaria ADEMA. Palma de Mallorca. España.
  4. 4 Atención Primaria de Mallorca. España.
Show affiliations +
Journal:
Anales del sistema sanitario de Navarra

ISSN: 1137-6627

Year of publication: 2022

Volume: 45

Issue: 1

Pages: 7-7

Type: Article

DOI: 10.23938/ASSN.0977 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Anales del sistema sanitario de Navarra

Abstract

Background. Obesity predisposes to type 2 diabetes so often that the combination is called diabesity. The aim of this study was to determine the prevalence of diabesity in the working population and to analyze the variables associated with it. Method. Cross-sectional study between January 2019 and June 2020 by 418,343 workers from 18 to 67 year-old, from different professions and Spanish geographic areas. The prevalence of diabesity was determined with six different formulae for obesity: BMI (body mass index), CUN BAE (Clínica Universidad de Navarra Body Adiposity Estimator), ECORE-BF (Equation Córdoba for Estimation of Body Fat), Formula Palafolls, FMI (fat mass index) of Deuremberg and RFM (relative fat mass). The association between diabetes and age, sex, social class and tobacco was analyzed. Results. The global prevalence of diabetes ranged from 2.6% for BMI to 5.8% for the Palafolls formula. The variable most related to diabesity was age over 50 years (OR = 5.9; 95%CI: 5.7-6.2 for BMI, and OR = 8.1; 95%CI: 7.9-8.4 for FMI of Deuremberg). Male sex and social class III related with diabesity estimated by all formulas, while being a smoker was only related with the Palafolls formula. Conclusion. Diabesity prevalence varies depending on the formula used, with much lower prevalence among women and increased with age independent of the formula used. Its prevalence is higher in the lower social classes.

Bibliographic References

  • Citas 1. LÓPEZ-GONZÁLEZ AA. Globesity: The modern epidemic that is fast becoming the biggest danger to world health. EC Endocrinology and Metabolic Research 2017; 1: 56-57.
  • FORGA L, PETRINA E, BARBERÍA JJ. Complicaciones de la obesidad. An Sist Sanit Navar 2009; 25 (Suppl 1): 117-126. https://doi.org/10.23938/ASSN.0820
  • PICHÉ ME, TCHERNOF A, DESPRÉS JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 2020; 126: 1477-1500. https://doi.org/10.1161/circresaha.120.316101
  • BARBANY M, FOZ M. Obesidad: concepto, clasificación y diagnóstico. An Sist Sanit Navar 2009; 25 (Suppl 1): 7-16. https://doi.org/ 10.23938/ASSN.0810
  • OKORODUDU D, JUMEAN M, MONTORI V, ROMERO-CORRAL A, SOMERS V, ERWIN P et al. Rendimiento diagnóstico del índice de masa corporal para identificar la obesidad definida por la adiposidad corporal: una revisión sistemática y un metanálisis. Int J Obes 2010; 34: 791-799. https://doi.org/10.1038/ijo.2010.5
  • FAEH D, WILLIAM J, TAPPY L, RAVUSSIN E, BOVET P. Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health 2007; 19: 163. https://doi.org/10.1186/1471-2458-7-163
  • RODRIGUEZ A, CATALÁN V, GÓMEZ-AMBROSI J, FRÜHBECK G. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic síndrome? Curr Pharm Des 2007; 13: 169-175. https://doi.org/10.2174/138161207781039599
  • OSNISHI H, SAITOH S, TAKAGI S, OHATA J, TAKEUCHI H, ISOBE T et al. Incidence of insulin resistance in obese subjects in a rural Japanese population: the Tanno and Sobetsu study. Diabetes Obes Metab 2005; 7: 83-87. https://doi.org/10.1111/j.1463-1326.2004.00381.x
  • POTENZA MA, NACCI C, DE SALVIA MA, SAGARRA L, COLLINO M, MONTAGNANI M. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options. Pharmacol Res 2017; 120: 226-241. https://doi.org/10.1016/j.phrs.2017.04.009
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1): S62-S69. https://doi.org/10.2337/dc10-S062
  • GÓMEZ-AMBROSI J, SILVA C, CATALÁN V, RODRÍGUEZ A, GALOFRÉ JC, ESCALADA J et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care 2012; 35: 383-388. https://doi.org/10.2337/dc11-1334
  • MOLINA-LUQUE R, ROMERO-SALDAÑA M, ÁLVAREZ-FERNÁNDEZ C, BENNASAR-VENY M, ÁLVAREZ-LÓPEZ Á, MOLINA-RECIO G. Equation Córdoba: a simplified method for estimation of body fat (ECORE-BF). Int J Environ Res Public Health 2019; 16: 4529. https://doi.org/10.3390/ijerph16224529
  • MILL-FERREYRA E, CAMENO-CARRILLO V, SAÚL-GORDO H, CAMÍ-LAVADO MC. Estimation of the percentage of body fat based on the body mass index and the abdominal circumference: Palafolls Formula. Semergen 2019; 45: 101-108. https://doi.org/10.1016/j.semerg.2018.04.007
  • DEURENBERG P, WETSTRATE JA, SEIDELL JC. Body mass index as a measure of body fatness: age- and sex- specific prediction formulas. Br J Nutr 1991; 65: 105-114. https://doi.org/10.1079/bjn19910073
  • WOOLCOTT OO, BERGMAN RN. Relative fat mass (RFM) as anew estimator of whole-body fat percentage. A cross-sectional study in American adult individuals. Sci Rep 2018; 8: 10980. https://doi.org/10.1038/s41598-018-29362-1
  • DOMINGO-SALVANY A, BACIGALUPE A, CARRASCO JM, ESPELT A, FERRANDO J, BORRELL C. Propuesta de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011. Gac Sanit 2013; 27: 263-272. https://doi.org/10.1016/j.gaceta.2012.12.009
  • ORIA E, LAFITA J, PETRINA E, ARGÜELLES I. Composición corporal y obesidad. An Sist Sanit Navar 2009; 25 (Suppl 1): 91-102. https://doi.org/ 10.23938/ASSN.0817
  • RODRÍGUEZ-RODRÍGUEZ E, LÓPEZ-PLAZA B, LÓPEZ-SOBALER A, ORTEGA R. Prevalencia de sobrepeso y obesidad en adultos españoles. Nutr Hosp 2011; 26: 355-363. https://doi.org/10.1590/S0212-16112011000200017
  • American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005; 28 (Suppl 1): s4-s36. https://doi.org/10.2337/diacare.28.suppl_1.S4
  • TOPLAK H, LEITNER DR, HARREITER J, HOPPICHLER F, WASCHER TC, SCHINDLER K, LUDVIK B. Diabesity - obesity and type 2 diabetes (update 2019). Wien Klin Wochenschr 2019; 131 (Suppl 1): 71-76. https://doi.org/10.1007/s00508-018-1418-9
  • PRADHAN AD, SKERRETT PJ, MANSON JE. Obesity, diabetes, and coronary risk in women. J Cardiovasc Risk 2002; 9: 323-330. https://doi.org/10.1097/01.hjr.0000044513.34172.83
  • KOLB H, MARTIN S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med 2017; 15: 131. https://doi.org/10.1186/s12916-017-0901-x
  • PAPPAS G, QUEEN S, HADEN W, FISHER G. The increasing disparity in mortality between socioeconomic groups in United States, 1960 and 1986. N Eng J Med 1993; 329: 103-109. https://doi.org/ 10.1056/NEJM199307083290207
  • NAVARRO V, BENACH J. Desigualdades sociales en salud en España. Informe de la Comisión Científica de estudios de las desigualdades sociales en Salud en España. Rev Esp Salud Publica 1996; 70: 505-636. https://www.mscbs.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL70/70_5_505.pdf
  • ARANCETA-BARTRINA J, PÉREZ-RODRIGO C, ALBERDI-ARESTI G, RAMOS-CARRERA N, LÁZARO-MASEDO S. Prevalencia de obesidad general y obesidad abdominal en la población adulta española (25–64 años) 2014–2015: estudio ENPE. Rev Esp Cardiol 2016; 69: 579-586. https://doi.org/10.1016/j.recesp.2016.02.010
  • PEARCE C, RYCHETNIK L, WUTZKE S, WILSON A. Obesity prevention and the role of hospital and community-based health services: a scoping review. BMC Health Serv Res 2019; 19: 453. https://doi.org/10.1186/s12913-019-4262-3
  • PANKOVA A, KRALIKOVA E, ZVOLSKA K, STEPANKOVA L, BLAHA M, OVESNA P et al. Early weight gain after stopping smoking: a predictor of overall large weight gain? A single-site retrospective cohort study. BMJ Open 2018; 8: e023987. https://doi.org/10.1136/bmjopen-2018-023987
  • NG ACT, DELGADO V, BORLAUG BA, BAX JJ. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol 2021; 18: 291-304. https://doi.org/10.1038/s41569-020-00465-5
  • Wells JCK. The diabesity epidemic in the light of evolution: insights from the capacity-load model. Diabetologia 2019; 62: 1740-1750. https://doi.org/10.1007/s00125-019-4944-8
Data source: Dialnet